You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Clopidogrel

Showing 1 - 25 of 1,574
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Coronary Syndrome, CYP2C19 Polymorphism Trial in Nieuwegein (Clopidogrel)

Recruiting
  • Acute Coronary Syndrome
  • CYP2C19 Polymorphism
  • Clopidogrel
  • Nieuwegein, Utrecht, Netherlands
    St. Antonius Hospital
Jun 27, 2023

COPD, COPD Exacerbation Acute Trial in Peshawar (Clopidogrel Bisulfate 75Mg Tab)

Not yet recruiting
  • COPD
  • COPD Exacerbation Acute
  • Clopidogrel Bisulfate 75Mg Tab
  • Peshawar, Khyber Pakhtunkhwa, Pakistan
    Pulmonology Department, Lady Reading Hospital, Peshawar
Aug 27, 2023

Ischemic Stroke Trial in Kafr Ash Shaykh (Ticagrelor 90 MG, Clopidogrel)

Recruiting
  • Ischemic Stroke
  • Ticagrelor 90 MG
  • Clopidogrel
  • Kafr Ash Shaykh, Egypt
    Kafr Elsheikh University Hospital
Nov 7, 2023

Stable Chronic Angina Trial in Shiraz (Clopidogrel, Ticagrelor)

Completed
  • Stable Chronic Angina
  • Shiraz, Iran, Islamic Republic of
    Professor Kojuri Cardiology Clinic
May 12, 2023

Ischemic Stroke Trial in Guangzhou (Aspirin, Clopidogrel, Alteplase)

Not yet recruiting
  • Ischemic Stroke
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Jun 11, 2023

Ticagrelor Versus Clopidogrel for CMD in AMI: A Retrospective

Completed
  • Coronary Heart Disease
  • Dual antiplatelet therapy with aspirin and either ticagrelor or clopidogrel
  • Hangzhou, Zhejiang, China
    Second affiliated Hospital Zhejiang University School of Medicin
Jul 31, 2023

Coronary Artery Disease, Platelet Reactivity Trial in Nieuwegein (Clopidogrel)

Not yet recruiting
  • Coronary Artery Disease
  • Platelet Reactivity
  • Clopidogrel
  • Nieuwegein, Utrecht, Netherlands
  • +1 more
Dec 9, 2022

Bleeding Complications Trial in Rochester (Clopidogrel, Prasugrel, Tricagrelor)

Active, not recruiting
  • Bleeding Complications
  • Clopidogrel
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Dec 31, 2022

Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)

Recruiting
  • Clopidogrel, Poor Metabolism of
  • Carotid Stenosis
  • San Donato Milanese, Milan, Italy
    IRCCS Policlinico San Donato
Sep 30, 2022

Incidence and Associated Outcomes in Patients With Cerebral Aneurysms Trial in Dallas

Recruiting
  • Incidence and Associated Outcomes in Patients With Cerebral Aneurysms
    • Dallas, Texas
      Methodist Dallas Medical Center
    Jul 6, 2023

    Coronary Artery Disease Trial in Seoul (Clopidogrel treatment group, No antiplatelet or anticoagulant group)

    Recruiting
    • Coronary Artery Disease
    • Clopidogrel treatment group
    • No antiplatelet or anticoagulant group
    • Seoul, Other, Korea, Republic of
      Seoul National University Hospital
    May 9, 2023

    Coronary Artery Disease Trial in Seoul (Clopidogrel monotherapy, Tailored anti-platelet therapy)

    Not yet recruiting
    • Coronary Artery Disease
    • Clopidogrel monotherapy
    • Tailored anti-platelet therapy
    • Seoul, Korea, Republic of
      Severance Hospital
    Jul 3, 2023

    Ischemic Stroke Trial in Kafr Ash Shaykh (Ticagrelor 90 MG Oral Tablet, Clopidogrel tablet)

    Recruiting
    • Ischemic Stroke
    • Ticagrelor 90 MG Oral Tablet
    • Clopidogrel tablet
    • Kafr Ash Shaykh, Egypt
      Kafr Elsheikh University Hospital
    Nov 18, 2022

    Coronary Artery Disease, Platelet Reactivity Trial (CYP2C19 genotype guided P2Y12 monotherapy, Clopidogrel)

    Not yet recruiting
    • Coronary Artery Disease
    • Platelet Reactivity
    • CYP2C19 genotype guided P2Y12 monotherapy
    • Clopidogrel
    • (no location specified)
    Mar 7, 2023

    Bioequivalence Trial in Yaroslavl (Clopidogrel film-coated tablet 75 mg, Plavix® film-coated tablet 75 mg)

    Recruiting
    • Bioequivalence
    • Clopidogrel film-coated tablet 75 mg
    • Plavix® film-coated tablet 75 mg
    • Yaroslavl, Yaroslavl Region, Russian Federation
      State Autonomous Healthcare Facility of the Yaroslavl Region "Cl
    Jun 28, 2023

    Severe Aortic Stenosis Trial in Seoul (Aspirin single antiplatelet therapy, Clopidogrel single antiplatelet therapy)

    Not yet recruiting
    • Severe Aortic Stenosis
    • Aspirin single antiplatelet therapy
    • Clopidogrel single antiplatelet therapy
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Aug 8, 2022

    Chronic Kidney Disease (CKD), Type 2 Diabetes (T2DM), Coronary Artery Disease (CAD) Trial in Jacksonville (Clopidogrel,

    Active, not recruiting
    • Chronic Kidney Disease (CKD)
    • +2 more
    • Clopidogrel
    • Clopidogrel active metabolite
    • Jacksonville, Florida
      University of Florida Jacksonville
    Aug 5, 2022

    Acute Coronary Syndrome, Percutaneous Coronary Intervention Trial in Hangzhou (Standard-DAPT of Ticagrelor plus aspirin,

    Not yet recruiting
    • Acute Coronary Syndrome
    • Percutaneous Coronary Intervention
    • Standard-DAPT of Ticagrelor plus aspirin
    • Sequential monotherapy of Ticagrelor and clopidogrel
    • Hangzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine at Zhejiang Universi
    Sep 20, 2022

    Metabolism of Clopidogrel Trial in Lancaster (Clopidogrel, Omeprazole/Clopidogrel)

    Completed
    Has Results
    • Metabolism of Clopidogrel
    • Lancaster, Pennsylvania
      Amish Research Clinic
    Feb 21, 2022

    Thrombosis Trial in Nanjing (Aspirin?clopidogrel? or SHR2285, Aspirin?ticagrelor? or SHR2285)

    Completed
    • Thrombosis
    • Aspirin、clopidogrel、placebo or SHR2285
    • Aspirin、ticagrelor、placebo or SHR2285
    • Nanjing, Jiangsu, China
      Nanjing Drum Tower Hospital
    Jun 30, 2022

    Ischemic Heart Disease Trial in Seoul (Clopidogrel monotherapy, Aspirin monotherapy, zotarolimus-eluting stent (Resolute Onyx

    Recruiting
    • Ischemic Heart Disease
    • Clopidogrel monotherapy
    • +2 more
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Oct 13, 2022

    Acute Coronary Syndrome Trial (Rivaroxaban 2.5 Mg Oral Tablet, Clopidogrel tablet, Aspirin tablet)

    Not yet recruiting
    • Acute Coronary Syndrome
    • Rivaroxaban 2.5 Mg Oral Tablet
    • +2 more
    • (no location specified)
    Oct 5, 2022

    Intracranial Aneurysm Trial in Gyeonggi-do (Prasugrel group, Clopidogrel group)

    Recruiting
    • Intracranial Aneurysm
    • Prasugrel group
    • Clopidogrel group
    • Gyeonggi-do, Yongin-si, Korea, Republic of
      Yongin Severance hospital, Yonsei university college of medicine
    Jul 13, 2022

    STEMI - ST Elevation Myocardial Infarction Trial in Zunyi (NOAC+DAPT, DAPT)

    Recruiting
    • STEMI - ST Elevation Myocardial Infarction
    • Zunyi, Guizhou, China
      Affiliated Hospital of Zunyi Medical University
    Aug 25, 2023

    Myocardial Infarction Patients Who Were PrescribedNovel

    Recruiting
    • Myocardial Infarction
      • Uijeongbu, Korea, Republic of
        The Catholic University of Korea, Uijeongbu ST. Mary's Hospital
      Oct 25, 2022